These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2127476)

  • 1. [Production of interleukin 2 and interferon-gamma in rheumatoid polyarthritis during a longitudinal study conducted on patients treated with methotrexate].
    Couret M; Combe B; Reme T; Sany J
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):641-5. PubMed ID: 2127476
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.
    McKenna RM; Wilkins JA; Warrington RJ
    J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
    Haroon N; Srivastava R; Misra R; Aggarwal A
    J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.
    Combe B; Pope RM; Fischbach M; Darnell B; Baron S; Talal N
    Clin Exp Immunol; 1985 Mar; 59(3):520-8. PubMed ID: 3921298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerance of methotrexate in rheumatoid polyarthritis. Results of an open study on 104 patients].
    Krause E; Combe B; Miossec P; Bataille R; Sany J
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):15-21. PubMed ID: 2657990
    [No Abstract]   [Full Text] [Related]  

  • 9. [Low-dose oral methotrexate in the treatment of rheumatoid polyarthritis].
    Chamot AM; Gerster JC; Van Melle G
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1267-71. PubMed ID: 3175573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study].
    Westedt ML; Dijkmans BA; Hermans J
    Rev Rhum Ed Fr; 1994 Oct; 61(9):591-7. PubMed ID: 7858592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
    Lampa J; Klareskog L; Rönnelid J
    J Rheumatol; 2002 Jan; 29(1):21-8. PubMed ID: 11824965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3643-8. PubMed ID: 3009609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-2 production by mononuclear cells of peripheral blood in patients with rheumatoid arthritis].
    Mazurov VI; Lila AM; Shelukhin VA; Blokhin MP; Zotkin EG
    Klin Med (Mosk); 1991 Mar; 69(3):89-91. PubMed ID: 2067349
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis treated with methotrexate. Study of 67 patients].
    Solé F; Arnal C; Sans J; Lience E
    Med Clin (Barc); 1991 Nov; 97(15):596. PubMed ID: 1805085
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate.
    Lacki JK; Mackiewicz SH; Wiktorowicz KE
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):287-90. PubMed ID: 7487368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate therapy in rheumatoid arthritis: 2-year retrospective followup study.
    Fehlauer CS; Carson CW; Cannon GW; Ward JR; Samuelson CO; Williams HJ; Clegg DO
    J Rheumatol; 1989 Mar; 16(3):307-12. PubMed ID: 2724249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
    Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.